Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
March 2005
2005:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2006 | 2007 | 2008 | 2009 | 2010
News | News in brief | News Features
News
Obesity expert owns up to million-dollar crime
A US physiologist is facing a possible prison sentence after pleading guilty to falsifying 17 grant applications to the National Institutes of Health (NIH) for nearly $3 million.
Nature (24 March 2005)
| Full Text |
No-confidence vote fails to shift Harvard president
Faculty members at Harvard University — encouraged by their own audacity in passing a vote of no confidence in their president — are planning to challenge him further.
Nature (24 March 2005)
| Full Text |
Academies seek better prospects for postdocs
The US National Institutes of Health (NIH) is being urged to introduce a set of reforms to improve the lot of postdocs and increase their chances of establishing independent scientific careers.
Nature (24 March 2005)
| Full Text |
US undervalues foreign researchers, survey reveals
Foreign postdocs in the United States work longer hours and publish more, but are paid less than their American counterparts, according to a poll of young scientists.
Nature (24 March 2005)
| Full Text |
Lawsuits and logistics tie up California's stem-cell funds
Biologists anticipating a stem-cell gold rush in California will have to wait a little longer, as a string of setbacks is slowing the state's plans to jump-start such research.
Nature (24 March 2005)
| Full Text |
Indian regulations fail to monitor growing stem-cell use in clinics
Two Indian government departments that have fought for years over who should control stem-cell research are finally negotiating a single set of guidelines for clinical practice.
Nature (17 March 2005)
| Full Text |
Rugby team converts to give gene tests a try
An Australian rugby league team claims it has gained a competitive edge over its rivals by using genetic tests to tailor its players' training programs, marking the beginning of a more widespread use of genetics in sport, according to geneticists.
Nature (17 March 2005)
| Full Text |
Plans for research watchdog praised, but it may lack teeth
British biomedical science is to get its first watchdog, but its architects have generated controversy by saying that they would consider accepting funding from the pharmaceutical industry.
Nature (17 March 2005)
| Full Text |
Senate resignations mar academy's birthday
The European Academy of Sciences and Arts in Salzburg, Austria, celebrated its 15th anniversary last weekend, but the party has been pooped by allegations of mismanagement.
Nature (10 March 2005)
| Full Text |
Career charter sets out rights of Europe's young scientists
A 'career charter' is to be published by the European Commission that, its backers say, will encourage higher standards for the treatment of junior researchers.
Nature (10 March 2005)
| Full Text |
Gene-therapy trials to restart following cancer risk review
Gene-therapy trials for children suffering from severe combined immunodeficiency disease (SCID) are set to resume in the United States, despite another cancer case in a French trial of the technique.
Nature (10 March 2005)
| Full Text |
Biosafety law brings stem-cell research to Brazil
Brazil has passed a landmark biosafety law that will legalize human embryonic stem-cell research, and may open the way for the cultivation of genetically modified crops.
Nature (10 March 2005)
| Full Text |
Science agencies get fresh paymasters in Republican revamp
NASA and the National Science Foundation (NSF) will answer to a new set of masters in Congress, following a wide-ranging shake-up of the committees that set their budgets.
Nature (10 March 2005)
| Full Text |
Maturing biotechs turn to pharma's markets
Certain maturing biotech companies have shifted their strategy to target broader, highly competitive markets traditionally served by big pharma.
Nature Biotechnology (March 2005)
| Full Text |
Synthetic biology offers alternative pathways to natural products
Industrial applications of synthetic biology are not as closeby as the media buzz makes us believe.
Nature Biotechnology (March 2005)
| Full Text |
Biotech consulting, investing by NIH scientists curbed
A new rule preventing NIH scientists from any outside employment by private organizations may not have such a negative effect on the biotech industry.
Nature Biotechnology (March 2005)
| Full Text |
Japanese giants renew interest in industrial biotech
Japanese corporations in seemingly unrelated areas such as automobile or electronics sector, are now investing in areas of life science.
Nature Biotechnology (March 2005)
| Full Text |
NIH workers see red over revised rules for conflicts of interest
The US National Institutes of Health (NIH) is facing a revolt by employees over its tightened rules on conflicts of interest.
Nature (03 March 2005)
| Full Text |
France lays plans for premier cancer centre in Toulouse
Europe's largest center for cancer research is to be built on the site of a major chemical explosion in France and will form the heart of one of France's seven new 'Cancéropôles' — regional networks of cancer research and care.
Nature (03 March 2005)
| Full Text |
Japanese call for more bite in animal rules
Animal-welfare activists are locking horns with researchers in Japan over how strictly the use of animals in the country's labs should be controlled.
Nature (03 March 2005)
| Full Text |
Protest letter accuses health agency of biodefence bias
Hundreds of US biologists have signed a letter protesting at what they see as the excessive use of bacteriology funds for the study of bioterror threats.
Nature (03 March 2005)
| Full Text |
Pasteur researchers win fight to stay in city centre
Scientists at the Pasteur Institute in Paris have won a long running battle over plans to move labs to a commercial zone on the outskirts of the city.
Nature (03 March 2005)
| Full Text |
Japan moves to combat Asia's escalating infectious diseases
With a new research initiative starting in April 2005, Japan is looking to take the lead in Asia's infectious disease studies.
Nature Medicine (March 2005)
| Full Text |
Medical researchers open eyes to tiny laboratories on a chip
Technology that shrinks laboratory procedures to the size of microchips is beginning to find applications in biomedical research.
Nature Medicine (March 2005)
| Full Text |
Action plan peps up Europe's mental health
In an attempt to tackle Europe's rocketing rates of depression, anxiety and suicide, the World Health Organization (WHO) launched an action plan in January to bolster mental health treatment and research.
Nature Medicine (March 2005)
| Full Text |
Antiaging drug trials compel creative testing methods
The day when doctors prescribe pills to combat aging may sound a long way off, but medical researchers are already starting to test such drugs in clinical trials.
Nature Medicine (March 2005)
| Full Text |
Meager US budget fails to assuage drug safety concerns
Research and drug safety advocates expressed frustration at President Bush's budget plan for the 2006 fiscal year, which boosts funding for the Food and Drug Administration (FDA) but leaves other biomedical agencies with marginal increases at best.
Nature Medicine (March 2005)
| Full Text |
News in brief
Panel holds the key to prison research rules
|Congress to consider ban on human cloning
|Change of head lifts gloom at primate centre
|UN compromise ends human cloning debate with 'non-binding' ban
|Duo leave government jobs after conflict hearings
|NSF to deter applicants for more grant success
|German prize winner misses ceremony after misconduct allegation
|India builds up research base with two institutes
|Environment agency gets scientist as head
|Marmoset heads queue for genome sequencing
|New biohub in Canada
|FDA under scrutiny
|Money for UK processing
|Incyte databases sold
|US law to curb gene bias
|Israeli association forms
|Indian institute gets cash to aim for the top
| Major lab finds home in heart of London
| Third cancer halts gene therapy trial
| French scientists protest at official research plans
News Features
Genetics: The X factor
The sequence of the 'feminine' X chromosome is a prime hunting ground for geneticists interested in the evolution of the cognitive and cultural sophistication that defines the human species. Erika Check reports.
Nature (17 March 2005)
| Full Text |
Counterfeit pharmaceuticals: Murder by medicine
Across the developing world, people are dying after being peddled fake pharmaceuticals. Peter Aldhous reports from southeast Asia, where scientists, doctors and regulators battle against organized crime.
Nature (10 March 2005)
| Full Text |
Clone on the range: What animal biotech is bringing to the table
Biotech animals don't have the market value of biotech drugs and potential controversies loom large, but genetic screening technologies are already finding a market, and both cloned and transgenic animals may soon be on the menu.
Nature (March 2005)
| Full Text |
US science policy: Upstart states
The United States has a settled arrangement for distributing its research budget around the country, and the same states have dominated it for decades. But, as Emma Marris discovers in Florida, the have-nots have had enough.
Nature (03 March 2005)
| Full Text |
A crucial test
Companies are racing to take therapies using RNA interference into clinical trials. Erika Check appraises the front runners — and the safety concerns that could hobble them.
Nature Medicine (March 2005)
| Full Text |
Profile: Mina Bissell
Cell biologist Mina Bissell left Iran at age eighteen and embarked on a career in American science. Her fearless approach and unconventional thinking have helped shape ideas about how breast tumors develop.
Nature Medicine (March 2005)
| Full Text |
|
